Antiangiogenesis
A new hypoxia-dependent agent inhibits tumor-specific neovascularization
Published in Cancer Weekly, April 22nd, 2003
According to published research from Japan, "tumor angiogenesis is initiated by angiogenic factors that are produced in large amounts by hypoxic tumor cells. The inhibition of this step may lead to tumor-specific antiangiogenesis because normal tissues are not usually hypoxic. On the other hand, blocking a biological function of endothelial cells is known to result in angiogenic inhibition."
"To produce a tumor-specific and powerful antiangiogenesis, we determined whether potent angiogenic inhibition could be achieved by inhibiting the production of angiogenic factors by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-04-22)
More Articles from Cancer Weekly
- Cancer Metastasis
Interleukin-1 is a prerequisite for tumor invasion and angiogenesis - Gene Detection
Dual "molecular beacons" might eventually lead to very early cancer diagnosis - Bladder Cancer
Hexvix cystoscopy improves treatment of patients - new phase III results - Body Mass Index
Height, but not weight or BMI, associated increases risk of testicular cancer - Liver Cancer
Researchers probe promising treatment - Sciatic Nerve Tumor
EMG and MRI used to diagnose sciatic nerve tumor in two dogs - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
